In last trading session, Precigen Inc (NASDAQ:PGEN) saw 1.1 million shares changing hands with its beta currently measuring 1.65. Company’s recent per share price level of $1.36 trading at $0.06 or 4.62% at ring of the bell on the day assigns it a market valuation of $398.30M. That closing price of PGEN’s stock is at a discount of -41.91% from its 52-week high price of $1.93 and is indicating a premium of 52.21% from its 52-week low price of $0.65. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.7 million shares which gives us an average trading volume of 1.52 million if we extend that period to 3-months.
For Precigen Inc (PGEN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.80. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.06 in the current quarter.
Precigen Inc (NASDAQ:PGEN) trade information
Upright in the green during last session for gaining 4.62%, in the last five days PGEN remained trading in the green while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $1.36 price level, adding 5.23% to its value on the day. Precigen Inc’s shares saw a change of 21.43% in year-to-date performance and have moved 1.49% in past 5-day. Precigen Inc (NASDAQ:PGEN) showed a performance of 87.25% in past 30-days. Number of shares sold short was 15.32 million shares which calculate 24.02 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 77.33% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -341.18% in reaching the projected high whereas dropping to the targeted low would mean a loss of -341.18% for stock’s current value.
Precigen Inc (PGEN) estimates and forecasts
Statistics highlight that Precigen Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -10.53% of value to its shares in past 6 months, showing an annual growth rate of -28.57% while that of industry is 16.10. Apart from that, the company came lowering its revenue forecast for fiscal year 2025. This year revenue growth is estimated to fall -35.67% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.3M for the same. And 3 analysts are in estimates of company making revenue of 733.33k in the next quarter. Company posted 1.23M and 1.06M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 36.94% during past 5 years.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Insiders are in possession of 10.17% of company’s total shares while institution are holding 63.83 percent of that, with stock having share float percentage of 71.06%. Investors also watch the number of corporate investors in a company very closely, which is 63.83% institutions for Precigen Inc that are currently holding shares of the company. PATIENT CAPITAL MANAGEMENT, LLC is the top institutional holder at PGEN for having 18.17 million shares of worth $28.72 million. And as of 2024-06-30, it was holding 7.2926 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 10.25 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.1116 of outstanding shares, having a total worth of $16.19 million.
On the other hand, Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 14.4 shares of worth $19.58 million or 4.92% of the total outstanding shares. The later fund manager was in possession of 5.45 shares on Sep 30, 2024 , making its stake of worth around $7.42 million in the company or a holder of 1.86% of company’s stock.
